Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Merabishvili, Maia ^a,b,c   Vandenheuvel, Dieter ^d   Kropinski, Andrew M ^e,f   Mast, Jan ^g   De Vos, Daniel ^a   Verbeken, Gilbert ^a   Noben, Jean Paul ^h   Lavigne, Rob ^d   Vaneechoutte, Mario ^c   Pirnay, Jean Paul ^a  

^a QUEEN ASTRID MILITARY HOSPITAL   (Belgium)

^b George Eliava Institute of Bacteriophage Microbiology and Virology   (Georgia)

^c GHENT UNIVERSITY   (Belgium)

^d LABORATORY OF GENE TECHNOLOGY   (Belgium)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f UNIVERSITY OF GUELPH   (Canada)

^g VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^h GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM MUTANT; CONTROLLED STUDY; GENOME ANALYSIS; GENOTYPE; HOST RANGE; INFECTION CONTROL; LIQUID CULTURE; MOLECULAR LIBRARY; MOLECULAR STABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE LIBRARY; PHIKMVLIKEVIRUS; PSEUDOMONAS AERUGINOSA PHAGE; SEQUENCE HOMOLOGY; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS LATENCY; CULTURE TECHNIQUE; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; PHENOTYPE; PHYSIOLOGY; PROTEOMICS; VIROLOGY;

ACINETOBACTER BAUMANNII; BACTERIOPHAGES; CULTURE TECHNIQUES; GENOME, VIRAL; HOST SPECIFICITY; MOLECULAR SEQUENCE ANNOTATION; PHENOTYPE; PROTEOMICS;

EID: 84905841643     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104853     Document Type: Article

References (73)

1. Davis KA, Moran KA, McAllister CK, Gray PJ (2005) Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 11: 1218-1224. (Pubitemid 41045329)
2. Jones A, Morgan D, Walsh A, Turton J, Livermore D, et al. (2006) Importation of multidrug-resistant Acinetobacter spp. infections with casualties from Iraq. Lancet Infect Dis 6: 317-318. (Pubitemid 43737279)
3. Petersen K, Riddle MS, Danko JR, Blazes DL, Hayden R, et al. (2007) Trauma-related infections in battlefield casualties from Iraq. Ann Surg 245: 803-811. (Pubitemid 46684112)
4. Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY (2013) Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther 11: 395-409.
5. Yang HY, Lee HJ, Suh JT, Lee KM (2009) Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 b-lactamase in a tertiary care hospital in Korea. Yonsei Med J 50: 764-770.
6. Fishbain J, Peleg AY (2010) Treatment of Acinetobacter infections. Clin Infect Dis 51: 79-84.
7. Mihu MR, Martinez LR (2011) Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections. Virulence 2: 97-102.
8. Lee BY, McGlone SM, Doi Y, Bailey RR, Harrison LH (2011) Economic value of Acinetobacter baumannii screening in the intensive care unit. Clin Microbiol Infect 17: 1691-1697.
9. Doi Y, Kandiah S, Hariri RS, Harrison LH (2012) Natural history of multi-drug resistant Acinetobacter baumannii carriage in intensive care units. Infect Control Hosp Epidemiol 33: 642-643.
10. Manchanda V, Sinha Sanchaita S, Singh NP (2010) Multidrug resistant Acinetobacter. J Glob Infect Dis 2: 291-304.
11. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
12. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, et al. (2006) Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 44: 2974-2976. (Pubitemid 44228598)
13. Pogue JM, Mann T, Barber KE, Kaye KS (2013) Carbapenem-resistant Acinetobacter baumannii : epidemiology, surveillance and management. Expert Rev Anti Infect Ther 11: 383-393.
14. Navon-Venezia S, Leavitt A, Carmeli Y (2007) High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 59: 772-774. (Pubitemid 47078722)
15. Dizbay M, Altuncekic A, Sezer BE, Ozdemir K, Arman D (2008) Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents 32: 29-32.
16. Cai Y, Chai D, Wang R, Liang B, Bai N (2012) Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. Antimicrob Chemother 67: 1607-1615.
17. Lin NT, Chiou PY, Chang KC, Chen LK, Lai MJ (2010) Isolation and characterization of phi AB2: a novel bacteriophage of Acinetobacter baumannii. Res Microbiol 161: 308-314.
18. Chang KC, Lin NT, Hu A, Lin YS, Chen LK, et al. (2011) Genomic analysis of bacteriophage φAB1, a phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Genomics 97: 249-255.
19. Popova AV, Zhilenkov EL, Myakinina VP, Krasilnikova VM, Volozhantsev NV (2012) Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol Lett 332: 40-46.
20. Shen GH, Wang JL, Wen FS, Chang KM, Kuo CF, et al. (2012) Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. Plos One 7: e46537. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone. 0046537. Accessed 5 October 2012.
21. Jeon J, Kim JW, Yong D, Lee K, Chong Y (2012) Complete genome sequence of the podoviral bacteriophage YMC/09/02/B1251 ABA BP, which causes the lysis of an OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolate from a septic patient. J Virol 86: 12437-12438.
22. Li P, Chen B, Song Z, Song Y, Yang Y, et al. (2012) Bioinformatic analysis of the Acinetobacter baumannii phage AB1 genome. Gene 507: 125-134.
23. Jin J, Li ZJ, Wang SW, Wang SM, Huang DH, et al. (2012) Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol 28: 156. Available: http://www.biomedcentral.com/1471-2180/12/156. Accessed 28 July 2012.
24. Huang G, Le S, Peng Y, Zhao Y, Yin S, et al. (2013) Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Curr Microbiol 66: 535-543.
25. Kropinski A, Prangishvili D, Lavigne R (2009) The creation of a rational scheme for the nomenclature of viruses of Bacteria and Archaea . Environm Microbiol 11: 2775-2777.
26. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B (2009) Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiol 155: 2333-2341.
27. Higgins PG, Hujer AM, Hujer KM, Bonomo RA, Seifert H (2012) Interlaboratory reproducibility of DiversiLab rep-PCR typing and clustering of Acinetobacter baumannii isolates. J Med Microbiol 61: 137-141.
28. Turton J F, Ward ME, Woodford N, Kaufmann ME, Pike R, et al. (2006) The role of ISAba1in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 258: 72-77.
29. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, et al. (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4: e4944. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone. 0004944.Accessed 2009 March 20.
30. Sambrook J, Russell DW (2001) Chapter 2: Bacteriophage λ and its vectors. In: Molecular cloning: A laboratory manual, ed. New York: Cold Spring Harbor Laboratory Press. 2.1-2.117.
31. Imberechts H, Wild P, Charlier G, De Greve H, Lintermans P, et al. (1996) Characterization of F18 fimbrial genes fedE and fedF involved in adhesion and length of enterotoxemic Escherichia coli strain 107/86. Microb Pathog 21: 183-192. (Pubitemid 26290569)
32. Adams MH (1959) Appendix: Methods of study of bacterial viruses. In: Bacteriophages. New York: Interscience Publishers. 443-522.
33. Appelmans R (1921) Le dosage du bactériophage. Compt Rend Soc Biol 85: 1098.
34. Merabishvili M, Verhelst R, Glonti T, Chanishvili N, Krylov V, et al. (2007) Digitized fluorescent RFLP analysis (fRFLP) as a universal method for comparing genomes of culturable dsDNA viruses: application to bacteriophages. Res Microbiol 158: 572-581. (Pubitemid 47488844)
35. Besemer J, Borodovsky M (1999) Heuristic approach to deriving models for gene finding. Nucl Acids Res 27: 3911-3920. (Pubitemid 29454440)
36. Delcher AL, Harmon D, Kasif S, White O, Salzberg SL (1999) Improved microbial gene identification with GLIMMER. Nucl Acids Res 27: 4636-4641.
37. Salzberg S, Delcher A, Kasif S, White O (1998) Microbial gene identification using interpolated Markov models. Nucl Acids Res 26: 544-548. (Pubitemid 28291582)
38. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 25: 3389-3402. (Pubitemid 27359211)
39. Altschul SF, Wootton JC, Gertz EM, Agarwala R, Morgulis A, et al. (2005) Protein database searches using compositionally adjusted substitution matrices. FEBS J 272: 5101-5109. (Pubitemid 41503143)
40. Söding J (2005) Protein homology detection by HMM-HMM comparison. Bioinformatics 21: 951-960.
41. Petersen TN, Brunak S, von Heijne G, Nielsen H (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions Nature Methods, 8: 785-786.
42. Krogh A, Larsson B, von Heijne G, Sonnhammer ELL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305: 567-580. (Pubitemid 33032862)
43. Laslett D, Canback B (2004) ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucl Acids Res 32: 11-16. (Pubitemid 38228599)
44. Lowe TM, Eddy SR (1997) tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucl Acids Res 25: 955-964. (Pubitemid 27298263)
45. Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Sec Int Conf Intell Syst Mol Biol: 28-36.
46. Gautheret D, Lambert A (2001) Direct RNA motif definition and identification from multiple sequence alignments using secondary structure profiles. J Mol Biol 313: 1003-1011. (Pubitemid 33081896)
47. Macke TJ, Ecker DJ, Gutell RR, Gautheret D, Case DA, et al. (2001) RNAMotif, an RNA secondary structure definition and search algorithm. Nucl Acids Res 29: 4724-4735. (Pubitemid 33095034)
48. Lavigne R, Sun WD, Volckaert G (2004) PHIRE, a deterministic approach to revel regulatory elements in bacteriophage genomes. Bioinformatics 20: 629-635. (Pubitemid 38443816)
49. Sullivan MJ, Patty NK, Beatson SA (2011) Easyfig: a genome comparison visualizer. Bioinformatics 27: 1009-1010.
50. Myers E, Miller W (1988) Optimal alignments in linear space. CABIOS 4: 11-17. (Pubitemid 18072011)
51. Rice P, Longden I, Bleasby A (2000) EMBOSS: the European molecular biology open software suite. Trends Genet 16: 276-277.
52. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
53. Moak M, Molineux IJ (2004) Peptidoglycan hydrolytic activities associated with bacteriophage virions. Mol Microbiol 51: 1169-1183. (Pubitemid 38270807)
54. Lavigne R, Noben JP, Hertveldt K, Ceyssens PJ, Briers Y, et al. (2006) The structural proteome of Pseudomonas aeruginosa bacteriophage phiKMV. Microbiol 152: 529-534. (Pubitemid 43210683)
55. Boucher HW, Talbot GH, Bradley JS et al. (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48: 1-12.
56. Hanlon GW (2005) The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol 41: 375-378.
57. Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, et al. (2013) OXA-235, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 57: 2121-2126.
58. Boo TW, Crowley B (2009) Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned? J Med Microbiol 58: 839-841.
59. Carvalho KR, Carvalho-Assef AP, Lia Galvão dos Santos L, Pereira M, Asensi M (2011) Occurrence of blaOXA-23gene in imipenem-susceptible Acinetobacter baumannii. Mem Inst Oswaldo Cruz, Rio de Janeiro 106: 505-506.
60. Higgins PG, Dammhayn C, Hackel M, Seifert H (2010) Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65: 233-238.
61. Soviet guidelines for production of liquid streptococcal phage preparation 167-80 (1980) Approved by the Ministry of Health of the USSR. [Russian].
62. Soviet guidelines for production of combined liquid pyobacteriophage preparation 242-82 (1982) Approved by the Ministry of Health of the USSR. [Russian].
63. Voroshilova N, Kazakova T, Gorbatkova G, Bogovazova G, Afanasieva E, et al. (1992) Method of production of Pyobacteriophage. Russian patent 2,036,232 C1, filed March 2, 1992 and issued May 27, 1995. [Russian].
64. Meipariani A, Alavidze Z, Dzidzishvili L, Chkonia I, et al. (2003) Method for production of mono and combined dry bacteriophage preparation. Georgian patent 20,063,943 B, filed June 11, 2003 and issued Oct. 10, 2006. [Georgian].
65. Weiss SB, Hsu WT, Foft JW, Schernerg NH (1968) Transfer RNA coded by the T4 bacteriophage genome. Proc Natl Acad Sci USA 61: 114-121.
66. Bailly-Bechet M, Vergassola M, Rocha E (2007) Causes for the intriguing presence of tRNAs in phages. Genome Res 17: 1486-1495. (Pubitemid 47529433)
67. Mikoulinskaia GV, Zimin AA, Feofanova SA, Miroshnikov AI (2007) A new broad specificity deoxyribonucleoside monophosphate kinase encoded by gene 52 of phage phi C31. Dokl Biochem Biophys 412: 15-7. (Pubitemid 46399326)
68. Ceyssens PJ, Lavigne R, Mattheus W, Chibeu A, Hertveldt K, et al. (2006) Genomic analysis of Pseudomonas aeruginosa phages LKD16 and LKA1: establishment of the phiKMV subgroup within the T7 supergroup. J Bacteriol 188: 6924-31. (Pubitemid 44497905)
69. Lee CN, Tseng TT, Lin JW, Fu YC, Weng SF, et al. (2011) Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2. Appl Environ Microbiol 77: 6755-6762.
70. Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, et al. (2010) Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J Infect Dis 201: 1096-1104.
71. Morello E, Saussereau E, Maura D, Huerre M, Touqui L, et al. (2011) Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention. PLoS One 6: e16963. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone. 0016963. Accessed 15 February 2011.
72. Uchiyama J, Rashel M, Takemura I, Kato S, Ujihara T, et al. (2012) Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10. Arch Virol 157: 733-738.
73. Lu S, Le S, Tan Y, Zhu J, Li M, et al. (2013) Genomic and proteomic analyses of the terminally redundant genome of the Pseudomonas aeruginosa phage PaP1: establishment of genus PaP1-like phages. PLoS One 8(5): e62933. Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062933. Accessed 2013 May 13.